Promise of endothelial progenitor cell for treatment of diabetic retinopathy

Ashay Bhatwadekar, Lynn C. Shaw, Maria B. Grant

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Progressive obliteration of the retinal microvessels is a characteristic of diabetic retinopathy. The resultant retinal ischemia leads to sight-threatening neovascularization and macular edema. Bone marrow-derived endothelial progenitor cells play a critical role in vascular maintenance and repair and forms the basis of cellular therapy for revascularization of ischemic myocardium and ischemic limbs. Emerging studies show potential of these cells in revascularization of ischemic retina and this review summarizes this possibility. We also report current pharmacological options to correct diabetes-associated defects in endothelial progenitor cells for their therapeutic transfer.

Original languageEnglish (US)
Pages (from-to)29-37
Number of pages9
JournalExpert Review of Endocrinology and Metabolism
Volume5
Issue number1
DOIs
StatePublished - Jan 2010
Externally publishedYes

Fingerprint

Diabetic Retinopathy
Macular Edema
Microvessels
Blood Vessels
Retina
Myocardium
Ischemia
Extremities
Bone Marrow
Maintenance
Pharmacology
Therapeutics
Endothelial Progenitor Cells

Keywords

  • Diabetic retinopathy
  • Endothelial nitric oxide synthase
  • Endothelial progenitor cell

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Promise of endothelial progenitor cell for treatment of diabetic retinopathy. / Bhatwadekar, Ashay; Shaw, Lynn C.; Grant, Maria B.

In: Expert Review of Endocrinology and Metabolism, Vol. 5, No. 1, 01.2010, p. 29-37.

Research output: Contribution to journalArticle

@article{3e6f0ec6c7aa41fcb5315d08ca084dad,
title = "Promise of endothelial progenitor cell for treatment of diabetic retinopathy",
abstract = "Progressive obliteration of the retinal microvessels is a characteristic of diabetic retinopathy. The resultant retinal ischemia leads to sight-threatening neovascularization and macular edema. Bone marrow-derived endothelial progenitor cells play a critical role in vascular maintenance and repair and forms the basis of cellular therapy for revascularization of ischemic myocardium and ischemic limbs. Emerging studies show potential of these cells in revascularization of ischemic retina and this review summarizes this possibility. We also report current pharmacological options to correct diabetes-associated defects in endothelial progenitor cells for their therapeutic transfer.",
keywords = "Diabetic retinopathy, Endothelial nitric oxide synthase, Endothelial progenitor cell",
author = "Ashay Bhatwadekar and Shaw, {Lynn C.} and Grant, {Maria B.}",
year = "2010",
month = "1",
doi = "10.1586/eem.09.75",
language = "English (US)",
volume = "5",
pages = "29--37",
journal = "Expert Review of Endocrinology and Metabolism",
issn = "1744-6651",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - Promise of endothelial progenitor cell for treatment of diabetic retinopathy

AU - Bhatwadekar, Ashay

AU - Shaw, Lynn C.

AU - Grant, Maria B.

PY - 2010/1

Y1 - 2010/1

N2 - Progressive obliteration of the retinal microvessels is a characteristic of diabetic retinopathy. The resultant retinal ischemia leads to sight-threatening neovascularization and macular edema. Bone marrow-derived endothelial progenitor cells play a critical role in vascular maintenance and repair and forms the basis of cellular therapy for revascularization of ischemic myocardium and ischemic limbs. Emerging studies show potential of these cells in revascularization of ischemic retina and this review summarizes this possibility. We also report current pharmacological options to correct diabetes-associated defects in endothelial progenitor cells for their therapeutic transfer.

AB - Progressive obliteration of the retinal microvessels is a characteristic of diabetic retinopathy. The resultant retinal ischemia leads to sight-threatening neovascularization and macular edema. Bone marrow-derived endothelial progenitor cells play a critical role in vascular maintenance and repair and forms the basis of cellular therapy for revascularization of ischemic myocardium and ischemic limbs. Emerging studies show potential of these cells in revascularization of ischemic retina and this review summarizes this possibility. We also report current pharmacological options to correct diabetes-associated defects in endothelial progenitor cells for their therapeutic transfer.

KW - Diabetic retinopathy

KW - Endothelial nitric oxide synthase

KW - Endothelial progenitor cell

UR - http://www.scopus.com/inward/record.url?scp=77949837340&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949837340&partnerID=8YFLogxK

U2 - 10.1586/eem.09.75

DO - 10.1586/eem.09.75

M3 - Article

AN - SCOPUS:77949837340

VL - 5

SP - 29

EP - 37

JO - Expert Review of Endocrinology and Metabolism

JF - Expert Review of Endocrinology and Metabolism

SN - 1744-6651

IS - 1

ER -